You just read:

BIOGEN Optimistic for Rapid and Broad Patient Access Following Invitation to Submit SPINRAZA® (nusinersen)▼ to National Institute for Health and Care Excellence (NICE) for Single Technology Appraisal (STA)

News provided by

Biogen

22 Jan, 2018, 09:30 GMT